Ambulatory surgery centers have long been positioned as the most cost-efficient setting in American healthcare — delivering the same procedures at a fraction of what hospitals charge. Yet a growing body of evidence suggests that ASC economics are being quietly eroded not through dramatic policy changes, but through a steady accumulation of payer tactics that compress reimbursement, inflate administrative costs, and redirect revenue to hospital outpatient departments. According to Becker’s ASC, ASC leaders across orthopedics, cardiology, anesthesia, and pain management are sounding the alarm: the financial model that made the ASC sector thrive is under sustained pressure — and for many practices, the revenue cycle is where the damage is felt first.
1. Rate Compression: Falling Behind Inflation
One of the most pervasive — and least visible — challenges facing ASCs today is the widening gap between what payers reimburse and what it actually costs to deliver care. While operational costs have risen sharply with inflation, facility reimbursement rates have not kept pace. Medicare, which sets the benchmark for commercial payer negotiations, reimburses ASCs at approximately 50% of hospital outpatient department rates for the same procedures. This structural disparity has existed for decades, but in the current inflationary environment, it is becoming increasingly difficult to sustain profitable operations. ASC leaders report that even when procedures are coded correctly and billed at contracted rates, the effective yield per case is shrinking year over year — a slow-moving revenue cycle crisis that compounds over time.
2. Prior Authorization Expansion: Administrative Burden as a Denial Strategy
Prior authorization requirements have exploded across ASC-relevant specialties, with 46% of ASC cases requiring preauthorization in 2024 — up from 42% in 2023. For orthopedics, spine, and interventional pain management, the prior auth burden is particularly severe. Insurers have systematically expanded the list of procedures requiring approval, extended decision timelines, and increased the documentation thresholds required to demonstrate medical necessity. In practice, this creates a dual revenue cycle problem: it delays scheduling and cash flow, and it opens a second avenue for denial — one where the payer can cite documentation gaps, not clinical inappropriateness. For multi-physician ASCs handling high volumes of elective orthopedic, spine, and cardiology cases, the cumulative staff hours dedicated to prior authorization management represent a material and growing cost that directly eats into net revenue.
3. Implant Carve-Outs: Hospitals Win, ASCs Absorb the Loss
In orthopedic and spine-driven ASCs, implant costs represent one of the largest and least predictable line items in the cost structure. The problem is compounded by how payers structure implant payment: hospital outpatient departments are typically reimbursed for implant costs separately — meaning they are “carved out” of the facility fee. ASCs, by contrast, are often locked into “pay one price” arrangements where the implant cost is bundled into the facility rate. As implant costs rise with newer device generations, ASCs are increasingly absorbing the difference. This dynamic is most acute in total joints, complex spine, and cardiac rhythm management — precisely the high-growth, high-acuity case types that ASCs have been expanding into. Without renegotiating implant language in payer contracts, ASCs are effectively subsidizing payer cost-containment strategies with their own margins.
4. Anesthesia Reimbursement: Quiet Cuts With Major Impact
Anesthesia groups affiliated with or contracted to ASCs are experiencing a parallel compression of their own. CMS finalized a reduction to the anesthesia conversion factor in its 2025 Physician Fee Schedule, while commercial payers simultaneously increased denials, bundled previously separately billable anesthesia services, and introduced modifier disputes that triggered payment reprocessing. The result: anesthesia providers are seeing effective reimbursement per unit decline even as case complexity increases. For ASCs that rely on employed or exclusive-contract anesthesiologists and CRNAs, this creates downstream pressure on the facility — since anesthesia availability, cost, and contracting are inseparable from the ASC’s operational economics. When anesthesia groups renegotiate contracts or reduce case availability at lower-reimbursing facilities, the ASC bears the operational consequence.
5. The Growing ‘Cost of Getting Paid’
Perhaps the most overlooked dimension of payer pressure on ASCs is not what they are reimbursed — but what it costs to collect it. Denial management, appeals, audit responses, authorization tracking, underpayment identification, and payer contract monitoring all require dedicated staff and infrastructure. As payer rules grow more complex, ASCs are investing in billing staff, technology, and external support at rates that outpace reimbursement growth. Industry data suggests the administrative cost of revenue cycle operations at ASCs has grown significantly over the past three years. For smaller and independent ASCs without the scale to absorb these overhead increases, the economics increasingly favor consolidation, partnership with health systems, or outsourcing revenue cycle functions to specialized billing firms — a structural shift that is accelerating across the sector.
What This Means for ASC Revenue Cycle Leaders
The payer tactics described by Becker’s ASC are not isolated incidents — they represent a coordinated, systemic pattern of reimbursement suppression that is reshaping ASC financial performance from the inside out. The combination of rate compression, expanded prior authorization, implant bundling, anesthesia cuts, and rising administrative costs creates an environment where even efficiently run ASCs are losing ground on a per-case basis. For revenue cycle leaders and ASC administrators, the challenge is not just to react to each denial or contract shortfall — but to build the infrastructure and expertise to detect, document, and counter these tactics at scale. That requires purpose-built ASC billing expertise, real-time payer performance analytics, and contract-level reimbursement benchmarking.
How Cosentus Helps
Cosentus specializes in revenue cycle management for surgical and specialty practices, including ASCs across orthopedics, spine, pain management, cardiology, and anesthesia. Our services are built to counteract the exact payer tactics described in this report:
Payer Contract Benchmarking: We audit your contracted rates against Medicare and market benchmarks, identifying where rate compression has gone unchallenged and building the data case for renegotiation.
Prior Authorization Management: Dedicated specialists manage your authorization workflows end-to-end — reducing delays, preventing authorization-related denials, and tracking approval timelines by payer and procedure.
Implant Billing Optimization: We work with your contracting team to identify carve-out opportunities in payer agreements and ensure implant costs are documented and billed to maximize recovery.
Anesthesia Revenue Cycle Support: Our anesthesia billing specialists handle conversion factor tracking, modifier optimization, and commercial payer denial management — protecting the revenue of your anesthesia partners.
Denial Analytics & Appeals: We track denial patterns by payer, CPT code, and modifier, identify systemic issues before they compound, and manage the full appeals lifecycle on your behalf.
Underpayment Recovery: Automated payer remittance auditing catches contractual underpayments — including implant carve-out violations — and initiates recovery workflows before timely filing limits expire.
Schedule a revenue cycle assessment with Cosentus: cosentus.com/contact
